A biology teacher and mother-of-two has become the first UK patient to receive a "gamechanger" therapy to treat multiple ...

Learn about multiple sclerosis, its symptoms, causes, and treatment options. Understand how early diagnosis helps in managing ...

Doctors are looking to recruit more people for the trial, which they say could one day be given as a single one-off treatment ...

Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...

The first patient has been dosed in a Phase 1 trial testing the experimental CAR T-cell therapy obecabtagene autoleucel for progressive MS.

The price of Rebif has increased four times faster than the rate of inflation, with Kay's insurer deciding to stop covering ...

"Multiple sclerosis: three trials to watch" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Bionxt launched the final animal study needed to prepare for human testing of BNT23001, its under-the-tongue version of ...

Updates in relapsing-remitting MS from ECTRIMS 2025 examine lifestyle interventions, anti-CD20 therapies, efficacy of fenebrutinib, and bone marrow transplantation as an effective long-term treatment.

NEW BERN, NC / ACCESS Newswire / October 28, 2025 / This September, 1,200 cyclists and hundreds of volunteers took part in ...

A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a ...

With ads everywhere for pro- or pre-biotic foods and supplements, most people are familiar with the gut microbiome—the ...